VANGUARD GROUP INC - VIRIOS THERAPEUTICS INC ownership

VIRIOS THERAPEUTICS INC's ticker is VIRI and the CUSIP is 92829J104. A total of 16 filers reported holding VIRIOS THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of VIRIOS THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$44,910
-55.1%
208,8830.0%0.00%
Q1 2024$100,076
-16.7%
208,8830.0%0.00%
Q4 2023$120,108
-37.8%
208,8830.0%0.00%
Q3 2023$193,175
-33.7%
208,883
-1.0%
0.00%
Q2 2023$291,175
+3709.2%
210,996
+914.5%
0.00%
Q1 2023$7,644
-78.2%
20,798
-86.0%
0.00%
Q4 2022$35,082
-61.9%
148,651
-38.5%
0.00%
Q3 2022$92,000
-91.0%
241,6660.0%0.00%
Q2 2022$1,022,000
-5.5%
241,6660.0%0.00%
Q1 2022$1,082,000
+42.9%
241,666
+63.4%
0.00%
Q4 2021$757,000
-3.2%
147,8660.0%0.00%
Q3 2021$782,000
-11.8%
147,866
+4.9%
0.00%
Q2 2021$887,000141,0110.00%
Other shareholders
VIRIOS THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
McCollum Christoferson Group LLC 57,000$12,2550.00%
William Howard & Co Financial Advisors Inc 10,072$20.00%
ONE PLUS ONE WEALTH MANAGEMENT, LLC 10,000$2,1500.00%
XTX Topco Ltd 42,650$9,1700.00%
NORTHERN TRUST CORP 24,035$5,1680.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
UBS Group AG 151,779$32,6320.00%
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO 19,062$4,0980.00%
GEODE CAPITAL MANAGEMENT, LLC 174,469$37,5160.00%
Activest Wealth Management 3,000$6450.00%
View complete list of VIRIOS THERAPEUTICS INC shareholders